Explore the latest in health care economics, insurance, and payment from The JAMA Network, including cost-effectiveness, value-based purchasing, and payment reform.
This study uses data from the US Nationwide Inpatient Sample to examine the association between regional hospital market concentration and hospital charges in a population of patients undergoing hepatopancreaticobiliary surgical procedures.
This study uses data from a large academic medical center to estimate the accuracy of the criteria used by Medicare to represent the burden of hospitalizations for heart failure.
This study examines PCSK9i cost-sharing requirements for Medicare Part D plans nationwide, which insure 41 million beneficiaries.
This study uses Medicare Drug Spending Dashboard data to estimate the cost of repository corticotropin to the Medicare program and assess its within-specialty prescribing patterns.
Using longitudinal data from the nationally representative Medical Expenditure Panel Survey, this study examines the association of insurance gains and losses with prescription drug access.
This Special Communication reviews the peer-reviewed medical and health policy literature to identify studies that described the different types of patent protection and regulatory exclusivities that shield brand-name prescription drugs from competition and help to sustain high drug prices.
This analysis of US Securities and Exchange Commission filings provides a contemporary estimate of research and development spending to develop 10 new cancer drugs.
This study evaluates changes in access to care for adults by mental health status using data from a national sample.
This study examines the association of higher patient cost sharing with mental health care use and downstream effects, such as involuntary commitment and acute mental health care use.
This data analysis simulates the annual price of evolocumab under the outcome-based contracts proposed by Amgen and puts estimates in the context of the available evidence on the cost-effectiveness of PCSK9 inhibitors.
This study analyzes a newly released government survey examining Medicaid beneficiaries’ experiences with and opinions of the Medicaid program.
This analysis of claims data compares physician reimbursement in Medicare Advantage, traditional Medicare, and commercial health insurance plans.
This difference-in-differences analysis tests whether extending CareFirst’s program to Medicare fee-for-service patients improves care processes and reduces hospitalizations, emergency department visits, and spending.
This population-based study evaluates the status of health coverage in 5 South Asian countries toward achievement of the United Nations’ Sustainable Development Goals.
This study of Medicare beneficiaries who had a laparoscopic gastric band placed explores how common reoperations were among this population and what costs were involved for payers.
This study of National Cancer Database records assesses the association of insurance and community-level socioeconomic status with outcomes for patients with squamous cell carcinoma of the pharynx.
This Viewpoint promotes using outcomes-based pricing strategies for proprotein convertase subtilisin/kexin type 9 inhibitors.